Trametinib plus 4-Methylumbelliferone Exhibits Antitumor Effects by ERK Blockade and CD44 Downregulation and Affects PD-1 and PD-L1 in Malignant Pleural Mesothelioma
Hiroyuki Cho(Kyoto University), Seiji Matsumoto(Hyogo Medical University), Yoshiko Fujita(Hyogo Medical University), Ayumi Kuroda(Hyogo Medical University), Toshi Menju(Kyoto University), Makoto Sonobe(Kyoto University), Nobuyuki Kondo(Hyogo Medical University), Ikuko Torii(Hyogo Medical University), Takashi Nakano(Hyogo Medical University), Primo N. Lara(University of California, Davis), David R. Gandara(University of California, Davis), Hiroshi Date(Kyoto University), Seiki Hasegawa(Hyogo Medical University)
Cited by 44
Abstract
Related Papers
No related papers found
Powered by citation graph analysis